Research Article
Association between Variation of Troponin and Prognosis of Acute Myocardial Infarction before and after Primary Percutaneous Coronary Intervention
Table 2
Characteristics of the △cTnI cohort versus cohort lack of repeated cTnI assessments.
| Variables | △cTnI cohort | Cohort lack of repeated cTnI assessments | value |
| N | 1138 | 2448 | ---- | Age (years) | 59(12.31) | 59(12.08) | 0.095 | Male (%(n)) | 68.5(779) | 79.0(1934) | ≤0.001 | BMI (kg/m2) | 25.99(3.76) | 26.01(7.85) | 0.917 | Heart rate (beats per minute) | 77.45(36.81) | 77.84(25.11) | 0.712 | Systolic blood pressure (mmHg) | 124(40) | 120(72) | 0.015 | Diastolic blood pressure (mmHg) | 77(25) | 71(20) | ≤0.001 | History of PCI (%(n)) | 9.8(111) | 12.5(306) | 0.019 | History of CABG (%(n)) | 0.9(10) | 0.8(20) | 0.845 | Hypertension (%(n)) | 59.3(675) | 59.7(1461) | 0.855 | Hyperlipidemia (%(n)) | 64.9(739) | 83.5(2043) | ≤0.001 | Smoking (%(n)) | 38.5(438) | 59.9(1465) | ≤0.001 | Diabetes (%(n)) | 32.2(366) | 32.6(799) | 0.561 | Total cholesterol (mg/dl) | 1.37(1.04) | 2.54(2.05) | ≤0.001 | HDL-cholesterol (mg/dl) | 3.15(1.82) | 2.35(2.03) | ≤0.001 | LDL-cholesterol (mg/dl) | 1.43(1.28) | 2.35(2.03) | ≤0.001 | Triglycerides (mg/dl) | 0.96(0.58) | 1.19(0.97) | ≤0.001 | ALT (IU/L) | 25.44(5.62) | 25.99(3.79) | 0.619 | Statin (%(n)) | 65.6(747) | 88.8(2174) | ≤0.001 | Aspirin (%(n)) | 67.0(762) | 63.6(1559) | 0.060 | Clopidogrel (%(n)) | 42.9(488) | 76.8(1879) | ≤0.001 | Ticagrelor (%(n)) | 27.0(307) | 16.9(414) | ≤0.001 | Warfarin (%(n)) | 0.2(2) | 0.5(13) | 0.167 | ACEI (%(n)) | 47.6(542) | 60.0(1469) | ≤0.001 | ARB (%(n)) | 5.9(67) | 7.1(175) | 0.174 | Beta-blockers (%(n)) | 62.0(706) | 82.5(2020) | ≤0.001 | Ezetimibe (%(n)) | 1.2(14) | 0.5(12) | 0.020 | Diuretic (%(n)) | 18.6(212) | 29.3(719) | ≤0.001 | MACE (%(n)) | 4.1(47) | 10.0(246) | ≤0.001 | Death (%(n)) | 2.3(26) | 7.7(189) | ≤0.001 | CV death (%(n)) | 1.2(13) | 6.4(157) | ≤0.001 | Stroke (%(n)) | 1.5(17) | 2.1(51) | 0.292 |
|
|
Continuous data are presented as mean ± SD or median (interquartile range); categorical variables are presented as % (n). PCI, percutaneous coronary intervention; BMI, body mass index; CABG, coronary artery bypass grafting; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride; ALT, alanine aminotransferase; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; MACE, major adverse cardiovascular events; CV death, cardiovascular death.
|